5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      ¿Influye la duración del dolor neuropático en la eficacia de pregabalina? Translated title: Does duration of neuropathic pain impact the effectiveness of pregabalin?

      letter
      ,
      Revista de la Sociedad Española del Dolor
      Inspira Network Group, S.L

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: not found

          A systematic review of the effect of waiting for treatment for chronic pain.

          In many countries timely access to care is a growing problem. As medical costs escalate health care resources must be prioritized. In this context there is an increasing need for benchmarks and best practices in wait-time management. The Canadian Pain Society struck a Task Force in December 2005 to identify benchmarks for acceptable wait-times for treatment of chronic pain. As part of the mandate a systematic review of the literature regarding the relationship between waiting times, health status and health outcomes for patients awaiting treatment for chronic pain was undertaken. Twenty-four studies met the inclusion criteria for the review. The current review supports that patients experience a significant deterioration in health related quality of life and psychological well being while waiting for treatment for chronic pain during the 6 months from the time of referral to treatment. It is unknown at what point this deterioration begins as results from the 14 trials involving wait-times of 10 weeks or less yielded mixed results with wait-times amounting to as little as 5 weeks, associated with deterioration. It was concluded that wait-times for chronic pain treatment of 6 months or longer are medically unacceptable. Further study is necessary to determine at what stage the deterioration begins from the onset of pain to treatment and the impact of waiting on treatment outcomes. Most important is the need to improve access to appropriate care for patients with chronic pain, an escalating public health care problem with significant human and economic costs.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Does Duration of Neuropathic Pain Impact the Effectiveness of Pregabalin?

            Patients with chronic pain conditions such as neuropathic pain frequently experience delays in diagnosis and treatment. Ideally, all patients should be treated in a timely manner, but in those patients with more established disease it is important to know that approved treatments remain effective.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cost savings associated with early initiation of pregabalin in the management of peripheral neuropathic pain.

              Peripheral neuropathic pain (PNP) is associated with significant economic burden. Guidelines recommend the early adoption of appropriate pharmacological interventions. The aim of this study was to explore whether early initiation of pregabalin was associated with lower economic burden, than later initiation, in the management of refractory chronic PNP.
                Bookmark

                Author and article information

                Contributors
                Role: ND
                Role: ND
                Journal
                dolor
                Revista de la Sociedad Española del Dolor
                Rev. Soc. Esp. Dolor
                Inspira Network Group, S.L (Madrid, Madrid, Spain )
                1134-8046
                August 2018
                : 25
                : 4
                : 246
                Affiliations
                [1] Badajoz orgnameHospital Don Benito-Villanueva de la Serena orgdiv1Unidad del Dolor España
                Article
                S1134-80462018000400246
                10.20986/resed.2016.3504/2016
                c0a2bf2c-b7b9-4f0c-baab-61c3637ab1bf

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                History
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 5, Pages: 1
                Product

                SciELO Spain


                Comments

                Comment on this article